Jubilant Pharmova names Arun Kumar Sharma as interim CFO
Noida: Jubilant Pharmova has announced the appointment of Arun Kumar Sharma as a Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from October 1, 2025.
He shall hold the CFO office for an interim period till the appointment of new CFO.
"we wish to inform that the Board of Directors of the Company, at its meeting held on September 23, 2025, on the recommendation of Nomination, Remuneration and Compensation Committee and the Audit Committee, had considered and approved the appointment of Mr. Arun Kumar Sharma as a Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from October 1, 2025," the company stated in a BSE filing.
"The appointment is made for an interim period to ensure a smooth transition to the new Chief Financial Officer, for which the identification and appointment process is in progress," it added.
Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses.
